House Oversight Committee Probes FDA’s Response to Baby Formula Shortage

Republicans on the House Oversight and Accountability Committee are pressing the U.S. Food and Drug Administration (FDA) for information about the agency’s response to the nationwide infant formula shortage.
In a March 21 letter (pdf) to FDA Commissioner Robert Califf, Committee Chairman James Comer (R-Ky.) and Rep. Lisa McClain (R-Mich.), chair of the Subcommittee on Health Care and Financial Services, expressed concern that the agency had been “superficial” in its efforts to “bring accountability and make meaningful changes” in the wake of the shortage.
“Formula shortages began in the summer of 2021 as global supply chains were disrupted by the COVID-19 pandemic,” the lawmakers wrote. “As the administration scrambled to contain the issue, families across the nation were presented with the question of how they would feed the infants in their families and communities….}